Utility of Cough Provocation Tests in Chronic Cough and Respiratory Diseases: A Comprehensive Review and Introduction of New Reference Ranges for the Capsaicin Test
Overview
Affiliations
Cough provocation tests (CPTs) are an objective measurement of the sensitivity of the cough reflex arc. However, they are not established in clinical practice because a large variability of response in healthy subjects limits their diagnostic value. There is a paucity of studies that have investigated CPT reference ranges in healthy subjects. This systematic review describes the variability of the responses to CPTs in healthy subjects and factors that influence it. A new analysis of 134 healthy subjects was conducted to create reference ranges for single-breath capsaicin CPT by calculating the interquartile ranges for the provocative concentration of capsaicin to induce 2 and 5 coughs. Female subjects had a more sensitive cough reflex than male counterparts. The ability of CPTs to distinguish various respiratory diseases from healthy subjects was also reviewed. Cough sensitivity was consistently heightened in the following groups: unselected patients with chronic, refractory, or recurrent cough, unexplained chronic cough, gastro-esophageal reflux-associated cough, cough-variant asthma, lower airway symptoms induced by chemical irritants, and fibrotic interstitial lung diseases. In the following groups, hypersensitivity of the cough reflex was present in those individuals whose symptom profile was predominated by cough: asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and sarcoidosis. In the following conditions, patients usually cough in order to expectorate mucus from their airways, not because of a hypersensitive cough reflex arc: productive cough, asthma, upper airway cough syndrome, COPD, bronchiectasis, cystic fibrosis, and chronic respiratory infections. CPTs have the potential to identify patients with chronic respiratory symptoms due to cough reflex hypersensitivity, thereby providing a targeted approach for therapy.
Khan D, Chaudhry H, Iqbal P, Shehzad D, Yasir M, Khan W J Community Hosp Intern Med Perspect. 2025; 14(6):75-81.
PMID: 39839174 PMC: 11745195. DOI: 10.55729/2000-9666.1417.
Repeat expansions in gene in refractory chronic cough.
Hirons B, Cho P, Rhatigan K, Shaw J, Curro R, Rugginini B ERJ Open Res. 2025; 11(1.
PMID: 39811557 PMC: 11726589. DOI: 10.1183/23120541.00584-2024.
The development of the Cough Hypersensitivity Questionnaire for chronic cough.
Hirons B, Cho P, Krageloh C, Siegert R, Turner R, Rhatigan K ERJ Open Res. 2024; 10(6).
PMID: 39624390 PMC: 11610079. DOI: 10.1183/23120541.00468-2024.
The Cough Response to Inhaled Mannitol in Healthy Subjects.
Nurmi H, Latti A, Koskela H Lung. 2024; 203(1):5.
PMID: 39607505 PMC: 11604684. DOI: 10.1007/s00408-024-00755-6.
Turner R, Birring S ERJ Open Res. 2024; 10(6).
PMID: 39559449 PMC: 11571073. DOI: 10.1183/23120541.00459-2024.